Products - Cervical cancer | Topic | NICE

Showing 3 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Tisotumab vedotin for treating recurrent or metastatic cervical cancer after systemic therapy [ID3753]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
LN-145 for treating recurrent, persistent or metastatic cervical cancer [ID3844]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Pembrolizumab with chemoradiation for untreated high-risk locally advanced cervical cancer [ID6138]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC